RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
EXPERT OPINION ON BIOLOGICAL THERAPY
Collezione AOU Città della Salute di Torino

Items : 9

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2022 Mar;22(3):407-421. doi: 10.1080/14712598.2021.1974394. Epub 2021 Sep 15.

2022
AOU Città della Salute di Torino

Moscato T; Irrera G; Console G; Ferreri A; Naso V; Sanguedolce C; Surace R; Pellicano' M; Pontari A; Loddo V; Rao CM; Scappatura G; Franzutti C; Curmaci F; Quattrone D; Moschella A; Gattuso C; Dattola V; Borzumati V; Morabito A; Florenzano MT; Amalfi V; Labate D; Germano' J; Alati C; Stelitano C; Imbalzano L; Russo L; Cusumano G; et alii...

Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2019 May;19(5):433-442. doi: 10.1080/14712598.2019.1594770. Epub 2019 Apr 8.

2019
AOU Città della Salute di Torino

Pucci G; Milan A; Paini A; Salvetti M; Cerasari A; Vaudo G;

CD38 as an immunotherapeutic target in multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov

2018
AOU Città della Salute di Torino

Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F; Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F;

Systemic virotherapy for multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2017 Nov;17(11):1375-1387. doi: 10.1080/14712598.2017.1364359. Epub 2017 Aug

2017
AOU Città della Salute di Torino

Oliva S; Gambella M; Boccadoro M; Bringhen S;

In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2017 Nov;17(11):1401-1415. doi: 10.1080/14712598.2017.1369949. Epub 2017 Aug

2017
AOU Città della Salute di Torino

Busca A; Aversa F;

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2017 Jul;17(7):821-836. doi: 10.1080/14712598.2017.1324567. Epub 2017 May 22.

2017
AOU Città della Salute di Torino

Patriarca F; Giaccone L; Onida F; Castagna L; Sarina B; Montefusco V; Mussetti A; Mordini N; Maino E; Greco R; Peccatori J; Festuccia M; Zaja F; Volpetti S; Risitano A; Bassan R; Corradini P; Ciceri F; Fanin R; Baccarani M; Rambaldi A; Bonifazi F; Bruno B; Patriarca F; Giaccone L; Onida F; Castagna L; Sarina B; Montefusco V; et alii...

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2016;16(3):347-64. doi: 10.1517/14712598.2015.1130821. Epub 2016 Feb 6.

2016
AOU Città della Salute di Torino

Martino M; Festuccia M; Fedele R; Console G; Cimminiello M; Gavarotti P; Bruno B;

Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2015 Jun;15(6):857-72. doi: 10.1517/14712598.2015.1036735. Epub 2015 Apr 12.

2015
AOU Città della Salute di Torino

Festuccia M; Martino M; Ferrando F; Messina G; Moscato T; Fedele R; Boccadoro M; Giaccone L; Bruno B;

Monoclonal antibodies currently in Phase II and III trials for multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2014 Aug;14(8):1127-44. doi: 10.1517/14712598.2014.908848. Epub 2014 Apr 21.

2014
AOU Città della Salute di Torino

Donato F; Gay F; Bringhen S; Troia R; Palumbo A;